Jubilant Pharmova sells stake in Sofie Biosciences for $139.4 million

JPL holds a 25.8% stake in Sofie Biosciences, which it acquired through its Singapore-based subsidiary Jubilant Pharma in November 2020 for $25 million.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news